ClevelandDx
Developer of a blood-based cancer diagnostics platform designed to improve clarity in disease detection. The company offers the IsoPSA test for prostate cancer, built on its IsoClear platform that mea...
Valuation
$285.2M
Latest known
Share Price
N/A
Total Raised
$126.1M
Last Round
N/A